claim: pyridoxal 5'-phosphate to mitigate cardiac dysregulation and coagulopathy in covid-19
evidence_1: pharmacological plp supplementation may therefore mitigate covid-19 symptoms by alleviating both the immune suppression underlying viral spread and the pathological hypersecretion of inflammatory cytokines, as well as directly bolstering endothelial integrity and preventing hypercoagulability.", "in inflammatory disease, pharmacological doses of plp decrease circulating tnfα, il-6 and d-dimer, and animal studies demonstrate that supplemental plp shortens the duration and severity of viral pneumonia."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )